Key result
A stepped-care depression prevention intervention did not significantly reduce the 24-month incidence of major depressive disorder compared with usual care (OR 1.37; 95% CI 0.52-3.55).
Why the study?
Does a stepped-care intervention prevent incident major depressive disorder compared with usual care in primary care patients with diabetes type 2 and/or coronary heart disease and subthreshold depression?
RCT (n=236)
cluster
Does a stepped-care intervention prevent incident major depressive disorder compared with usual care in primary care patients with diabetes type 2 and/or coronary heart disease and subthreshold depression?
Odds Ratio: 1.37 (95% CI 0.52–3.55)
A stepped-care intervention did not significantly reduce the 2-year incidence of major depressive disorder in primary care patients with diabetes and/or coronary heart disease with subthreshold depression.
Stepped-care prevention does not reduce 2-year MDD incidence in DM2/CHD; leaves open refined targeting by anxiety, depression, multimorbidity and stress.
Introduction Major depressive disorders (MDD), diabetes mellitus type 2 (DM2) and coronary heart disease (CHD) are leading contributors to the global burden of disease and often co-occur. Objectives To evaluate the 2-year effectiveness of a stepped-care intervention to prevent MDD compared with usual care and to develop a prediction model for incident depression in patients with DM2 and/or CHD with subthreshold depression. Methods Data of 236 Dutch primary care patients with DM2/CHD with subthreshold depression (Patient Health Questionnaire 9 (PHQ-9) score ≥6, no current MDD according to the Mini International Neuropsychiatric Interview (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria)) who participated in the Step-Dep trial were used. A PHQ-9 score of ≥10 at minimally one measurement during follow-up (at 3, 6, 9, 12 and 24 months) was used to determine the cumulative incidence of MDD. Potential demographic and psychological predictors were measured at baseline via web-based self-reported questionnaires and evaluated using a multivariable logistic regression model. Model performance was assessed with the Hosmer-Lemeshow test, Nagelkerke’s R 2 explained variance and area under the receiver operating characteristic curve (AUC). Bootstrapping techniques were used to internally validate our model. Results 192 patients (81%) were available at 2-year follow-up. The cumulative incidence of MDD was 97/192 (51%). There was no statistically significant overall treatment effect over 24 months of the intervention (OR 1.37; 95% CI 0.52 to 3.55). Baseline levels of anxiety, depression, the presence of >3 chronic diseases and stressful life events predicted the incidence of MDD (AUC 0.80, IQR 0.79–0.80; Nagelkerke’s R 2 0.34, IQR 0.33–0.36). Conclusion A model with 4 factors predicted depression incidence during 2-year follow-up in patients with DM2/CHD accurately, based on the AUC. The Step-Dep intervention did not influence the incidence of MDD. Future depression prevention programmes should target patients with these 4 predictors present, and aim to reduce both anxiety and depressive symptoms. Trial registration number NTR3715.
No takes yet. Share an insight, caveat, or question.
Pols et al. (2018) conducted an RCT in Type 2 diabetes and/or coronary heart disease with subthreshold depression (n=236). Stepped-care depression prevention intervention vs. Usual care was evaluated on Cumulative incidence of major depressive disorder (OR 1.37, 95% CI 0.52-3.55). A stepped-care depression prevention intervention did not significantly reduce the 24-month incidence of major depressive disorder compared with usual care (OR 1.37; 95% CI 0.52-3.55).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: